Scott Tarriff, CEO: Eagle Pharmaceuticals EGRX Sell · Filed 23/05/15

Trade details

Type: Insider sale
Amount: $311,688
Shares · price: 14,800 sh · $21.06 a share
Held after: 1,595,134 sh
Stock: Eagle Pharmaceuticals EGRX
Person: Scott TarriffCEO
Trade date: 23/05/15
Filed: 23/05/15
Days to filing: 0 days

Sold 0.9% of holdings

Share of holding sold: 0.9%

Eagle Pharmaceuticals trades, last 26 weeks

What else happened in Eagle Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/04/15~23/06/14

Scott Tarriff's recent trades

Scott TarriffCEO
Sell10b5-1 planEagle Pharmaceuticals
Sell10b5-1 plan
Eagle Pharmaceuticals
EGRX
$151K
10,925 sh
$151K
Filed 23/11/03
Traded 23/11/01
Scott TarriffCEO
Sell10b5-1 planEagle Pharmaceuticals
Sell10b5-1 plan
Eagle Pharmaceuticals
EGRX
$148.3K
10,694 sh
$148.3K
Filed 23/11/03
Traded 23/11/02
Scott TarriffCEO
Sell10b5-1 planEagle Pharmaceuticals
Sell10b5-1 plan
Eagle Pharmaceuticals
EGRX
$144.9K
9,511 sh
$144.9K
Filed 23/10/04
Traded 23/10/02
Scott TarriffCEO
Sell10b5-1 planEagle Pharmaceuticals
Sell10b5-1 plan
Eagle Pharmaceuticals
EGRX
$144.4K
10,024 sh
$144.4K
Filed 23/10/04
Traded 23/10/03
Scott TarriffCEO
Sell10b5-1 planEagle Pharmaceuticals
Sell10b5-1 plan
Eagle Pharmaceuticals
EGRX
$10.7K
710 sh
$10.7K
Filed 23/10/04
Traded 23/10/03